Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer

[1]  Baoan Ma,et al.  Mechanisms of breast cancer bone metastasis. , 2010, Cancer letters.

[2]  A. Kallioniemi,et al.  Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? , 2010, Endocrine-related cancer.

[3]  C. Luparello.  Midregion PTHrP and Human Breast Cancer Cells , 2010, TheScientificWorldJournal.

[4]  G. Djordjević,et al.  Role of bone morphogenetic proteins in human prostate cancer pathogenesis and development of bone metastases: immunohistochemical study. , 2010, Collegium antropologicum.

[5]  Vilppu J. Tuominen,et al.  Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4 , 2010, Breast Cancer Research and Treatment.

[6]  蔡輔仁,et al.  Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/FAK/Akt and NF-kB-dependent pathway , 2009 .

[7]  F. Tsai,et al.  Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. , 2009, Lung cancer.

[8]  M. El-Tanani,et al.  Role of osteopontin in cellular signaling and metastatic phenotype. , 2008, Frontiers in bioscience : a journal and virtual library.

[9]  Ke Pan,et al.  Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma , 2008, Journal of Cancer Research and Clinical Oncology.

[10]  Anna Teti,et al.  Bone metastasis: pathogenesis and therapeutic implications , 2007, Clinical & Experimental Metastasis.

[11]  R. Coleman.  Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.

[12]  P. Kuo,et al.  Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. , 2006, Surgery.

[13]  A. Ochiai,et al.  [Mechanism of osteoblastic bone metastasis of prostate cancer]. , 2006, Clinical calcium.

[14]  J. Hopper,et al.  Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. , 2006, Cancer research.

[15]  T. Yoneda,et al.  Crosstalk between cancer cells and bone microenvironment in bone metastasis. , 2005, Biochemical and biophysical research communications.

[16]  Paul J. Williams,et al.  C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. , 2003, Cancer research.

[17]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[18]  A. Waage,et al.  Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. , 2001, Blood.

[19]  V. Castronovo,et al.  Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  Yin-kun Liu,et al.  The role of sialoproteins in recognition of bone surface by osteoblasts via integrin , 1997 .

[21]  V. Castronovo,et al.  Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. , 1994, Cancer research.

[22]  M C Farach-Carson,et al.  Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. , 1993, The Journal of biological chemistry.